RBC Capital Maintains Outperform on Biohaven, Raises Price Target to $23

Benzinga · 3d ago
RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Outperform and raises the price target from $22 to $23.